We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Simvastatin reduces VEGF and NO levels in acute stages of experimental traumatic brain injury.
- Authors
Yüksel, Hatice; Yavuz, Özlem; Iş, Merih; Çomunoğlu, Nil; Üzüm, Gülay; Akyüz, Feyzullah; Yıldırım, Hayriye Ak
- Abstract
This study was undertaken to evaluate the effect of simvastatin, a cholesterol-lowering agent, on vascular endothelial growth factors (VEGFs), nitric oxide (NO) levels and neuroprotection, in rats with experimentally induced traumatic brain injury (TBI). Forty Wistar albino rats were categorized into four groups: sham operated (S), trauma (T), trauma + vehicle (T + V) and trauma + simvastatin (T + S). The T, T + V and T + S groups were subjected to TBI. The T + V group was administered vehicle [ethanol:saline (1/2)] and the T + S group was administered 1 mg/kg of simvastatin 3 h after the injury insult. Blood and brain tissue specimens were obtained 24 h after the trauma to measure VEGFs and NO levels and perform histopathological examinations. The histopathological injury scores of brain tissues were significantly higher in the T group, and simvastatin significantly prevented brain injury in the T + S group. In the T group, significant increases of VEGF levels in serum and brain tissues were noted, which were prevented with simvastatin treatment in the T + S group. The markedly high levels of NO in brain tissues of the T group were decreased by simvastatin treatment in the T + S group. It can be concluded that, as evidenced by histopathological findings, simvastatin treatment improves neuropathology in acute stages of TBI.
- Subjects
SIMVASTATIN; VASCULAR endothelial growth factors; NITRIC oxide; BRAIN injuries; ANTICHOLESTEREMIC agents; NEUROPROTECTIVE agents; HISTOPATHOLOGY
- Publication
Neurological Sciences, 2013, Vol 34, Issue 11, p1941
- ISSN
1590-1874
- Publication type
Article
- DOI
10.1007/s10072-013-1411-z